91 related articles for article (PubMed ID: 8096852)
41. Immune control of HIV-1 replication.
Walker BD; Rosenberg ES; Hay CM; Basgoz N; Yang OO
Adv Exp Med Biol; 1998; 452():159-67. PubMed ID: 9889969
[No Abstract] [Full Text] [Related]
42. Clonal expansion of T cells and HIV genotypes in microdissected splenic white pulps indicates viral replication in situ and infiltration of HIV-specific cytotoxic T lymphocytes.
Cheynier R; Henrichwark S; Hadida F; Pelletier E; Oksenhendler E; Autran B; Wain-Hobson S
Adv Exp Med Biol; 1995; 374():173-82. PubMed ID: 7572391
[TBL] [Abstract][Full Text] [Related]
43. Rate of killing of HIV-infected T cells and disease progression.
Huynen MA; Neumann AU
Science; 1996 Jun; 272(5270):1962. PubMed ID: 8658174
[No Abstract] [Full Text] [Related]
44. A lesson from the HIV patient: the immune response is still the bane (or promise) of gene therapy.
Koenig S
Nat Med; 1996 Feb; 2(2):165-7. PubMed ID: 8574959
[No Abstract] [Full Text] [Related]
45. Optimized Peptide-MHC Multimer Protocols for Detection and Isolation of Autoimmune T-Cells.
Dolton G; Zervoudi E; Rius C; Wall A; Thomas HL; Fuller A; Yeo L; Legut M; Wheeler S; Attaf M; Chudakov DM; Choy E; Peakman M; Sewell AK
Front Immunol; 2018; 9():1378. PubMed ID: 30008714
[TBL] [Abstract][Full Text] [Related]
46. Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination.
Martinez DR; Permar SR; Fouda GG
Clin Vaccine Immunol; 2016 Feb; 23(2):84-94. PubMed ID: 26656117
[TBL] [Abstract][Full Text] [Related]
47. In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants.
Kidzeru EB; Hesseling AC; Passmore JA; Myer L; Gamieldien H; Tchakoute CT; Gray CM; Sodora DL; Jaspan HB
AIDS; 2014 Jun; 28(10):1421-30. PubMed ID: 24785950
[TBL] [Abstract][Full Text] [Related]
48. Association of HIV diversity and survival in HIV-infected Ugandan infants.
James MM; Wang L; Musoke P; Donnell D; Fogel J; Towler WI; Khaki L; Nakabiito C; Jackson JB; Eshleman SH
PLoS One; 2011 Apr; 6(4):e18642. PubMed ID: 21533179
[TBL] [Abstract][Full Text] [Related]
49. Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment.
Huang S; Dunkley-Thompson J; Tang Y; Macklin EA; Steel-Duncan J; Singh-Minott I; Ryland EG; Smikle M; Walker BD; Christie CD; Feeney ME
J Immunol; 2008 Dec; 181(11):8103-11. PubMed ID: 19018003
[TBL] [Abstract][Full Text] [Related]
50. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.
Legrand FA; Nixon DF; Loo CP; Ono E; Chapman JM; Miyamoto M; Diaz RS; Santos AM; Succi RC; Abadi J; Rosenberg MG; de Moraes-Pinto MI; Kallas EG
PLoS One; 2006 Dec; 1(1):e102. PubMed ID: 17183635
[TBL] [Abstract][Full Text] [Related]
51. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.
Pillay T; Zhang HT; Drijfhout JW; Robinson N; Brown H; Khan M; Moodley J; Adhikari M; Pfafferott K; Feeney ME; St John A; Holmes EC; Coovadia HM; Klenerman P; Goulder PJ; Phillips RE
J Virol; 2005 Sep; 79(18):12100-5. PubMed ID: 16140787
[TBL] [Abstract][Full Text] [Related]
52. Not all tetramer binding CD8+ T cells can produce cytokines and chemokines involved in the effector functions of virus-specific CD8+ T lymphocytes in HIV-1 infected children.
Scott-Algara D; Buseyne F; Porrot F; Corre B; Bellal N; Rouzioux C; Blanche S; Riviere Y
J Clin Immunol; 2005 Jan; 25(1):57-67. PubMed ID: 15742158
[TBL] [Abstract][Full Text] [Related]
53. Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children.
Feeney ME; Roosevelt KA; Tang Y; Pfafferott KJ; McIntosh K; Burchett SK; Mao C; Walker BD; Goulder PJ
J Virol; 2003 Jul; 77(13):7492-501. PubMed ID: 12805449
[TBL] [Abstract][Full Text] [Related]
54. Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load.
Buseyne F; Scott-Algara D; Porrot F; Corre B; Bellal N; Burgard M; Rouzioux C; Blanche S; Rivière Y
J Virol; 2002 Dec; 76(24):12414-22. PubMed ID: 12438567
[TBL] [Abstract][Full Text] [Related]
55. Neonates mount robust and protective adult-like CD8(+)-T-cell responses to DNA vaccines.
Zhang J; Silvestri N; Whitton JL; Hassett DE
J Virol; 2002 Dec; 76(23):11911-9. PubMed ID: 12414933
[TBL] [Abstract][Full Text] [Related]
56. Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.
Buseyne F; Chaix ML; Rouzioux C; Blanche S; Rivière Y
J Virol; 2001 May; 75(10):4941-6. PubMed ID: 11312369
[TBL] [Abstract][Full Text] [Related]
57. Timing of lymphocyte activation in neonates infected with human immunodeficiency virus.
Gallagher K; Gorre M; Harawa N; Dillon M; Wafer D; Stiehm ER; Bryson Y; Song D; Dickover R; Plaeger S
Clin Diagn Lab Immunol; 1997 Nov; 4(6):742-7. PubMed ID: 9384301
[TBL] [Abstract][Full Text] [Related]
58. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection.
Klenerman P; Phillips RE; Rinaldo CR; Wahl LM; Ogg G; May RM; McMichael AJ; Nowak MA
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15323-8. PubMed ID: 8986810
[TBL] [Abstract][Full Text] [Related]
59. Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection.
Aldhous MC; Watret KC; Mok JY; Bird AG; Froebel KS
Clin Exp Immunol; 1994 Jul; 97(1):61-7. PubMed ID: 8033422
[TBL] [Abstract][Full Text] [Related]
60. Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS.
Van Rompay KK; Otsyula MG; Marthas ML; Miller CJ; McChesney MB; Pedersen NC
Antimicrob Agents Chemother; 1995 Jan; 39(1):125-31. PubMed ID: 7695293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
